Plasma GFAP and NLRP3 Associate with Cognitive Impairment After Recent Small Subcortical Infarct via Periventricular White Matter Hyperintensity
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70780 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Tianxiang Lan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, White Matter, Cognitive Dysfunction, Glial Fibrillary Acidic Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Aim
To assess whether early plasma inflammatory proteins identify SVD‐related stroke patients at high risk of cognitive impairment and to examine imaging‐mediated effects.
Methods
This single‐center retrospective study (April 2020–August 2024) enrolled patients with MRI‐confirmed recent small subcortical infarct (RSSI) and healthy controls. GFAP and NLRP3 levels were measured by ELISA. MRI markers of small vessel disease—including white matter hyperintensities (WMH), lacunes, perivascular spaces, and microbleeds—were evaluated. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and functional outcome by the modified Rankin Scale (mRS) at 3 months. Associations were analyzed using correlation, regression, and mediation analyses.
Results
A total of 108 RSSI patients and 47 controls were included (mean age 57.9 ± 10.5 years; 64.1% male). RSSI patients had significantly higher plasma GFAP and NLRP3 levels ( p < 0.05). Both proteins were inversely associated with total MoCA scores and cognitive subdomains, but not with 3‐month mRS. GFAP and NLRP3 correlated positively with periventricular WMH (PWMH). Mediation analysis showed that PWMH accounted for 23.88%–28.10% of the association between plasma protein levels and cognitive impairment.
Conclusions
Elevated plasma GFAP and NLRP3 are associated with post‐stroke cognitive impairment in RSSI, partially mediated by PWMH. These biomarkers may help identify patients at risk of early cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
- Centre of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Tianxiang Lan, Shuai Jiang, Bo Wu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- West China Hospital, Sichuan University
Zitieren
APA
Lan, T., Wang, C., Yan, Y., Yang, T., Cui, J., Lei, R., Luo, R., Jiang, S., & Wu, B. (2026). Plasma GFAP and NLRP3 Associate with Cognitive Impairment After Recent Small Subcortical Infarct via Periventricular White Matter Hyperintensity. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70780
Vancouver
Lan T, Wang C, Yan Y, Yang T, Cui J, Lei R, et al. Plasma GFAP and NLRP3 Associate with Cognitive Impairment After Recent Small Subcortical Infarct via Periventricular White Matter Hyperintensity. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70780
BibTeX
@article{Lan2026,
author = {Lan, Tianxiang and Wang, Chunhua and Yan, Yuying and Yang, Tang and Cui, Jingyu and Lei, Rumei and Luo, Rongfeng and Jiang, Shuai and Wu, Bo},
title = {Plasma GFAP and NLRP3 Associate with Cognitive Impairment After Recent Small Subcortical Infarct via Periventricular White Matter Hyperintensity},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70780}
}
EUVIMED